Taysha Gene Therapies, Inc. TSHA Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $7.47M+3.4% | $9.77M+17.3% | $6.31M-36.4% | $8.1M-37.1% | $7.22M-49.0% | ||
| $104.65M+71.8% | $86.4M+30.9% | $76.78M+21.2% | $65.98M+9.6% | $60.91M-6.2% | ||
| $35.39M+17.9% | $33.87M+17.0% | $31.66M+9.0% | $31.29M+5.2% | $30.03M+5.8% | ||
| —— | —— | —— | —— | —— | ||
| $140.03M+46.2% | $120.27M+20.5% | $108.44M+11.0% | $102.1M+12.2% | $95.77M+1.5% | ||
| $140.03M+46.2% | $120.27M+20.5% | $108.44M+11.0% | $102.1M+12.2% | $95.77M+1.5% | ||
| -$132.56M-49.7% | -$110.5M-20.8% | -$102.13M-16.4% | -$94M-20.3% | -$88.55M-10.4% | ||
| -1,774.4%-549pp | -1,130.6%-33.1pp | -1,618.5%-733pp | -1,160.8%-554pp | -1,225.8%-659pp | ||
| $53K-42.4% | $63K-38.2% | $73K-90.8% | $82K-96.3% | $92K-97.5% | ||
| $10.48M+59.5% | $9.22M+32.9% | $8.05M+12.5% | $6.99M+13.5% | $6.57M— | ||
| $2.69M+50.6% | $1.5M-30.4% | $2.2M— | $1.28M— | $1.78M— | ||
| —— | —— | —— | —— | —— | ||
| -$129.88M-49.7% | -$109M-22.1% | -$99.93M— | -$92.72M— | -$86.77M— | ||
| -1,738.4%-537pp | -1,115.3%-43.6pp | -1,583.7%— | -1,145%— | -1,201.1%— | ||
| -$0.38-11.8% | -$0.34+5.6% | -$0.33— | -$0.34— | -$0.34— | ||
| -$0.38-11.8% | -$0.34+5.6% | -$0.33— | -$0.34— | -$0.34— | ||
| 1.3B+31.1% | 1.2B+26.3% | 1.2B+38.1% | 1.1B+53.7% | 1B+89.8% | ||
| 1.3B+31.1% | 1.2B+26.3% | 1.2B+38.1% | 1.1B+53.7% | 1B+89.8% | ||
| $6.11M+20.7% | $6.17M+34.6% | $5.07M+14.8% | $5.24M+69.0% | $5.06M+129% | ||
| $1.3M+386% | $1.2M+7,594% | $380K— | $13K— | -$455K— | ||
| -$335K-264% | -$291K-165% | -$327K-388% | -$371K-7,320% | -$92K-109% | ||
| -$132.56M-49.7% | -$110.5M-20.8% | -$102.13M-16.4% | -$94M-20.3% | -$88.55M-10.4% | ||
| -$131.47M-50.5% | -$109.42M-21.3% | -$101.04M-16.8% | -$92.82M-20.8% | -$87.36M-10.8% | ||
| -$131.47M-50.5% | -$109.42M-21.3% | -$101.04M-16.8% | -$92.82M-20.8% | -$87.36M-10.8% | ||
| -1,759.7%-550pp | -1,119.6%-36.8pp | -1,601.3%-729pp | -1,146.2%-549pp | -1,209.3%-653pp | ||
| -$132.56M-49.7% | -$110.5M-20.8% | -$102.13M-16.4% | -$94M-20.3% | -$88.55M-10.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Taysha Gene Therapies, Inc.'s income statement data come from?
- Every line is extracted from Taysha Gene Therapies, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.